Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Adjuvants and formulations: how to make an immunogen from an antigen.

Virelizier JL.

Biologicals. 2009 Jun;37(3):139-40. doi: 10.1016/j.biologicals.2009.02.007. Epub 2009 Mar 26.

PMID:
19328011
2.

Rationale for treating human influenza infections by passive transfer of specific antibodies.

Virelizier JL.

Influenza Other Respir Viruses. 2007 Mar;1(2):61-4. doi: 10.1111/j.1750-2659.2007.00012.x.

3.

Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.

Burleigh L, Lozach PY, Schiffer C, Staropoli I, Pezo V, Porrot F, Canque B, Virelizier JL, Arenzana-Seisdedos F, Amara A.

J Virol. 2006 Mar;80(6):2949-57.

4.

Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals.

Lozach PY, Burleigh L, Staropoli I, Navarro-Sanchez E, Harriague J, Virelizier JL, Rey FA, Desprès P, Arenzana-Seisdedos F, Amara A.

J Biol Chem. 2005 Jun 24;280(25):23698-708. Epub 2005 Apr 26.

5.

CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes.

Balabanian K, Harriague J, Décrion C, Lagane B, Shorte S, Baleux F, Virelizier JL, Arenzana-Seisdedos F, Chakrabarti LA.

J Immunol. 2004 Dec 15;173(12):7150-60.

6.

WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.

Balabanian K, Lagane B, Pablos JL, Laurent L, Planchenault T, Verola O, Lebbe C, Kerob D, Dupuy A, Hermine O, Nicolas JF, Latger-Cannard V, Bensoussan D, Bordigoni P, Baleux F, Le Deist F, Virelizier JL, Arenzana-Seisdedos F, Bachelerie F.

Blood. 2005 Mar 15;105(6):2449-57. Epub 2004 Nov 9.

7.

C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles.

Lozach PY, Amara A, Bartosch B, Virelizier JL, Arenzana-Seisdedos F, Cosset FL, Altmeyer R.

J Biol Chem. 2004 Jul 30;279(31):32035-45. Epub 2004 May 27.

8.

Immunological assays and correlates of immunity.

Virelizier JL.

Dev Biol (Basel). 2003;115:123-32. No abstract available.

PMID:
15088784
9.

Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses.

Navarro-Sanchez E, Altmeyer R, Amara A, Schwartz O, Fieschi F, Virelizier JL, Arenzana-Seisdedos F, Desprès P.

EMBO Rep. 2003 Jul;4(7):723-8.

10.

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2.

Lozach PY, Lortat-Jacob H, de Lacroix de Lavalette A, Staropoli I, Foung S, Amara A, Houles C, Fieschi F, Schwartz O, Virelizier JL, Arenzana-Seisdedos F, Altmeyer R.

J Biol Chem. 2003 May 30;278(22):20358-66. Epub 2003 Feb 27.

11.

Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications.

Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, Altare F, Baretto R, Le Deist F, Kayal S, Koch H, Richter D, Brezina M, Aksu G, Wood P, Al-Jumaah S, Raspall M, Da Silva Duarte AJ, Tuerlinckx D, Virelizier JL, Fischer A, Enright A, Bernhöft J, Cleary AM, Vermylen C, Rodriguez-Gallego C, Davies G, Blütters-Sawatzki R, Siegrist CA, Ehlayel MS, Novelli V, Haas WH, Levy J, Freihorst J, Al-Hajjar S, Nadal D, De Moraes Vasconcelos D, Jeppsson O, Kutukculer N, Frecerova K, Caragol I, Lammas D, Kumararatne DS, Abel L, Casanova JL.

J Exp Med. 2003 Feb 17;197(4):527-35.

12.

G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolates.

Amara A, Vidy A, Boulla G, Mollier K, Garcia-Perez J, Alcamí J, Blanpain C, Parmentier M, Virelizier JL, Charneau P, Arenzana-Seisdedos F.

J Virol. 2003 Feb;77(4):2550-8.

13.

Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells.

Chanel C, Staropoli I, Baleux F, Amara A, Valenzuela-Fernandez A, Virelizier JL, Arenzana-Seisdedos F, Altmeyer R.

AIDS. 2002 Nov 22;16(17):2337-40.

PMID:
12441808
14.

HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains.

Percherancier Y, Lagane B, Planchenault T, Staropoli I, Altmeyer R, Virelizier JL, Arenzana-Seisdedos F, Hoessli DC, Bachelerie F.

J Biol Chem. 2003 Jan 31;278(5):3153-61. Epub 2002 Nov 12.

15.

Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4.

Valenzuela-Fernández A, Planchenault T, Baleux F, Staropoli I, Le-Barillec K, Leduc D, Delaunay T, Lazarini F, Virelizier JL, Chignard M, Pidard D, Arenzana-Seisdedos F.

J Biol Chem. 2002 May 3;277(18):15677-89. Epub 2002 Feb 26.

16.

Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes.

Beisser PS, Laurent L, Virelizier JL, Michelson S.

J Virol. 2001 Jul;75(13):5949-57.

17.

Palmitoylation-dependent control of degradation, life span, and membrane expression of the CCR5 receptor.

Percherancier Y, Planchenault T, Valenzuela-Fernandez A, Virelizier JL, Arenzana-Seisdedos F, Bachelerie F.

J Biol Chem. 2001 Aug 24;276(34):31936-44. Epub 2001 Jun 4.

18.

Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycans.

Valenzuela-Fernández A, Palanche T, Amara A, Magerus A, Altmeyer R, Delaunay T, Virelizier JL, Baleux F, Galzi JL, Arenzana-Seisdedos F.

J Biol Chem. 2001 Jul 13;276(28):26550-8. Epub 2001 May 14.

19.

Inducible NF-kappaB activation is permitted by simultaneous degradation of nuclear IkappaBalpha.

Renard P, Percherancier Y, Kroll M, Thomas D, Virelizier JL, Arenzana-Seisdedos F, Bachelerie F.

J Biol Chem. 2000 May 19;275(20):15193-9.

20.

Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin.

Pablos JL, Amara A, Bouloc A, Santiago B, Caruz A, Galindo M, Delaunay T, Virelizier JL, Arenzana-Seisdedos F.

Am J Pathol. 1999 Nov;155(5):1577-86.

21.

Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis.

Bodaghi B, Slobbe-van Drunen ME, Topilko A, Perret E, Vossen RC, van Dam-Mieras MC, Zipeto D, Virelizier JL, LeHoang P, Bruggeman CA, Michelson S.

Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2598-607.

PMID:
10509655
22.

Blocking HIV co-receptors by chemokines.

Virelizier JL.

Dev Biol Stand. 1999;97:105-9. Review.

PMID:
10463536
23.

Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine.

Amara A, Lorthioir O, Valenzuela A, Magerus A, Thelen M, Montes M, Virelizier JL, Delepierre M, Baleux F, Lortat-Jacob H, Arenzana-Seisdedos F.

J Biol Chem. 1999 Aug 20;274(34):23916-25.

24.

High frequency of the 3'A mutation of the SDF-1 gene in Cambodia.

Rousset D, Soares JL, Reynes JM, Caruz A, Flye Sainte Marie F, Virelizier JL.

AIDS. 1999 Feb 25;13(3):420-1. No abstract available.

PMID:
10199235
25.

Kinetics of transcription of human cytomegalovirus chemokine receptor US28 in different cell types.

Zipeto D, Bodaghi B, Laurent L, Virelizier JL, Michelson S.

J Gen Virol. 1999 Mar;80 ( Pt 3):543-7.

PMID:
10091991
26.
27.

Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells.

Bodaghi B, Jones TR, Zipeto D, Vita C, Sun L, Laurent L, Arenzana-Seisdedos F, Virelizier JL, Michelson S.

J Exp Med. 1998 Sep 7;188(5):855-66.

28.
29.

Genomic organization and promoter characterization of human CXCR4 gene.

Caruz A, Samsom M, Alonso JM, Alcami J, Baleux F, Virelizier JL, Parmentier M, Arenzana-Seisdedos F.

FEBS Lett. 1998 Apr 17;426(2):271-8.

30.

Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F, Virelizier JL, Baggiolini M, Sykes BD, Clark-Lewis I.

EMBO J. 1997 Dec 1;16(23):6996-7007.

31.

HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene.

Quillent C, Oberlin E, Braun J, Rousset D, Gonzalez-Canali G, Métais P, Montagnier L, Virelizier JL, Arenzana-Seisdedos F, Beretta A.

Lancet. 1998 Jan 3;351(9095):14-8.

PMID:
9433423
32.

Nuclear export signal of IkappaBalpha interferes with the Rev-dependent posttranscriptional regulation of human immunodeficiency virus type I.

Bachelerie F, Rodriguez MS, Dargemont C, Rousset D, Thomas D, Virelizier JL, Arenzana-Seisdedos F.

J Cell Sci. 1997 Nov;110 ( Pt 22):2883-93.

33.

The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome.

Kroll M, Conconi M, Desterro MJ, Marin A, Thomas D, Friguet B, Hay RT, Virelizier JL, Arenzana-Seisdedos F, Rodriguez MS.

Oncogene. 1997 Oct 9;15(15):1841-50.

34.

TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function.

Loetscher M, Amara A, Oberlin E, Brass N, Legler D, Loetscher P, D'Apuzzo M, Meese E, Rousset D, Virelizier JL, Baggiolini M, Arenzana-Seisdedos F, Moser B.

Curr Biol. 1997 Sep 1;7(9):652-60.

35.

Modulation of RANTES production by human cytomegalovirus infection of fibroblasts.

Michelson S, Dal Monte P, Zipeto D, Bodaghi B, Laurent L, Oberlin E, Arenzana-Seisdedos F, Virelizier JL, Landini MP.

J Virol. 1997 Sep;71(9):6495-500.

36.

HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication.

Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, Arenzana-Seisdedos F.

J Exp Med. 1997 Jul 7;186(1):139-46.

37.

European contribution to the science, prevention and management of HIV infection.

Lehner T, Biberfeld P, Boucher C, Darbyshire J, Fenyö EM, Heeney JL, Jager JC, Lundgren JD, Newell ML, Rösch P, Rossi P, Virelizier JL.

Vaccine. 1997 Apr;15(5):465-8.

PMID:
9160511
38.

TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.

Dal Monte P, Landini MP, Sinclair J, Virelizier JL, Michelson S.

AIDS. 1997 Mar;11(3):297-303.

PMID:
9147420
39.

Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm.

Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay RT, Virelizier JL, Dargemont C.

J Cell Sci. 1997 Feb;110 ( Pt 3):369-78.

40.

HIV blocked by chemokine antagonist.

Arenzana-Seisdedos F, Virelizier JL, Rousset D, Clark-Lewis I, Loetscher P, Moser B, Baggiolini M.

Nature. 1996 Oct 3;383(6599):400. No abstract available.

PMID:
8837769
41.

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.

Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B.

Nature. 1996 Aug 29;382(6594):833-5. Erratum in: Nature 1996 Nov 21;384(6606):288.

PMID:
8752281
42.

Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.

Rodriguez MS, Wright J, Thompson J, Thomas D, Baleux F, Virelizier JL, Hay RT, Arenzana-Seisdedos F.

Oncogene. 1996 Jun 6;12(11):2425-35.

PMID:
8649784
43.

Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.

Jacqué JM, Fernández B, Arenzana-Seisdedos F, Thomas D, Baleux F, Virelizier JL, Bachelerie F.

J Virol. 1996 May;70(5):2930-8.

44.

Stably expressed antisense RNA to cytomegalovirus UL83 inhibits viral replication.

Dal Monte P, Bessia C, Ripalti A, Landini MP, Topilko A, Plachter B, Virelizier JL, Michelson S.

J Virol. 1996 Apr;70(4):2086-94.

45.

Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A.

Michelson S, Turowski P, Picard L, Goris J, Landini MP, Topilko A, Hemmings B, Bessia C, Garcia A, Virelizier JL.

J Virol. 1996 Mar;70(3):1415-23.

46.

HIV genome transcription induced by polyoma virus middle T antigen through both enhancer- and promoter-dependent LTR activation.

Jacqué JM, Vlach J, Virelizier JL, Garcia A.

C R Acad Sci III. 1995 Dec;318(12):1227-32.

PMID:
8745637
47.

Influence of redox status of lymphocytes and monocytes on HIV transcription and replication.

Gougerot-Pocidalo MA, Aillet F, Virelizier JL, Israël N.

Immunobiology. 1995 Jul;193(2-4):204-9. Review. No abstract available.

PMID:
8530144
48.

Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.

Vlach J, Garcia A, Jacqué JM, Rodriguez MS, Michelson S, Virelizier JL.

Virology. 1995 Apr 20;208(2):753-61.

49.

How HIV may escape the activating effects of TNF.

Virelizier JL.

Res Immunol. 1994 Oct-Dec;145(8-9):690-3; discussion 694-6. Review. No abstract available.

PMID:
7754221
50.

Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1.

Michelson S, Alcami J, Kim SJ, Danielpour D, Bachelerie F, Picard L, Bessia C, Paya C, Virelizier JL.

J Virol. 1994 Sep;68(9):5730-7.

Supplemental Content

Loading ...
Support Center